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ABSTRACT  
A simple, accurate, precise, sensitive, rapid and economical spectrophotometric 
method was developed and validated for simultaneous estimation of Alprazolam 
(ALP) and Mebeverine HCl (MBH) in bulk drug and pharmaceutical formulation. The 
estimation of these drugs was carried out by using 0.1M HCl as a solvent. The 
wavelength maxima for Alprazolam and Mebeverine HCl were found to be 262.3 nm 
and 222.5 nm. The linearity range was observed in the concentration range of 3-15 
µg/ml for both drugs and regression equation was found to be for ALP 
0.0565x+0.0138 and for MBH 0.049x-0.0126. Percentage recoveries for Alprazolam 
and Mebeverine HCl were found to be 99.84% and 99.47% respectively. % RSD values 
for Intra-day precision were found to be for ALP 1.18% and for MBH 0.59%. Inter-day 
precision %RSD values were found to be for ALP 0.94% and for MBH 0.69%. LOD was 
found to be for ALP 1.42 (µg/ml) and for MBH 2.1542 (µg/ml). LOQ was found to be 
for ALP 4.3242 (µg/ml) and for MBH 6.5442 (µg/ml). The %Assay of Alprazolam and 
Mebeverine HCl were found to be 99.20% and 100.02% respectively. Statistical 
analysis proved that the developed method can be successfully used for simultaneous 
analysis of Alprazolam and Mebeverne HCl in pure and tablet dosage forms. 
INTRODUCTION
Alprazolam [Fig. 1] is chemically 8-chloro-1-methyl-
6-phenyl-4H-s-triazolo[4,3-α][1,4] benzodiazepine[1]. 
It is a short-acting anxiolytic of the benzodiazepine 
class of psychoactive drugs[2,3]. Alprazolam 
possesses anxiolytic, sedative, hypnotic, skeletal 
muscle relaxant, anti-convulsant and amnestic 
properties. The exact mechanism of action 
of Alprazolam is unknown.  Benzodiazepines bind 
nonspecifically to benzodiazepine receptors BNZ1, 
which mediates sleep, and BNZ2, which affects 
muscle relaxation, anticonvulsant activity, motor 
coordination, and memory. As benzodiazepine 
receptors are thought to be coupled to gamma-
aminobutyric acid-A (GABAA) receptors, this 
enhances the effects of GABA by increasing GABA 
affinity for the GABA receptor. Binding of the 
inhibitory neurotransmitter GABA to the site opens 
the chloride channel, resulting in a hyperpolarized 
cell membrane that prevents further excitation of the 
cell[4]. 
 
Fig. 1: Structure of Alprazolam 
Mebeverine Hydrochloride [Fig. 2] is chemically 4-
[ethyl-[1-(4-methoxyphenyl)propan-2yl]amino] 
buty l-3,4- dimethoxybenzoate hydrochloride[5]. It is 
an  anti-muscarinic and belongs to a group of 
compounds called musculotropic antispasmodics. 
These compounds act directly on the gut muscles at 
the cellular level to relax them. This relieves painful 
muscle spasms of the gut, without affecting its 
normal motility[6]. Mebeverine is used to relieve 
symptoms of irritable bowel syndrome and related 
IJRAPS, 2017:1(1):27-32 
 Website: http://ijraps.in  28 
intestinal disorders that are the result of spasms in 
the intestinal muscles. Mebeverine is also an 
inhibitor of calcium-depot replenishment. 
Therefore, it has dual mode of action which 
normalizes the small bowel motility[7,8]. 
 
Fig. 2: Structure of Mebeverine HCl 
The literature survey demonstrated that few 
analytical methods like TLC[9], HPTLC[10] and HPLC 
methods were described for estimation of 
Alprazolam and Mebeverine HCl in single[11-13] and 
combined[14] dosage form. However only one UV 
Spectrophotometric[15] method was available for 
determination of these drugs in combined dosage 
form. Hence the objective of the present work is to 
develop and validate a new, simple, sensitive, 
precise and accurate UV Spectrophotometric 
method for the simultaneous estimation of 
Alprazolam and Mebeverine Hydrochloride in bulk 
drug and in pharmaceutical formulations. 
MATERIALS AND METHODS 
Instrument 
Shimadzu UV1800 Double Beam UV-Visible 
Spectro-photometer was used for analysis. 
Chemical and Reagents 
The reference samples of Alprazolam (API) and 
Mebeverine Hydrochloride (API) were provided as 
gift samples from Sumages Pharma Pvt. Ltd., 
Bhimavaram, India. The commercial formulations 
(tablets) (MEBASAP-AL tablets containing 0.25 mg 
of Alprazolam and 135 mg of Mebeverine 
Hydrochloride) were procured from the local 
market. Hydrochloric acid (AR grade) was 
purchased from E.Merck (India) Ltd., Mumbai, India 
and was used as solvent. Fresh purified distilled 
water was used throughout the experiment. 
Selection of solvent 
Based on the solubility of the compounds finally 0.1M 
Hydrochloric acid was selected as common solvent for 
both the drugs due to its positive results.  
Detection of wave length maxima 
The spectra of diluted solutions contains 10 µg/ml 
of ALP and MBH were recorded separately on UV 
spectrophotometer and the solutions were scanned 
between 200-400 nm by using 0.1M Hydrochloric 
acid as blank. The peaks of maximum absorbance 
wavelengths were observed at 262.3 nm for ALP 
and 222.5 nm for MBH. The overlain spectra give 
the isobestic point at 263.9 nm. 
Standard solution of Alprazolam and Mebeverine 
HCl 
About 5 mg of Alprazolam and 5 mg of Mebeverine 
Hydrochloride was accurately weighed and 
transferred into a 100 ml clean dry volumetric flask 
containing 70 ml of 0.1M Hydrochloric acid. The 
solution was sonicated for 5 min and the drug was 
dissolved completely. The volume was made up to 
the mark with a further quantity of the 
Hydrochloric acid to get a stock concentration of 
Alprazolam and Mebeverine Hydrochloride. Further 
pipette 1 ml of the above stock solution into a 10 ml 
volumetric flask and the volume was made up to the 
mark with the 0.1M Hydrochloric acid. 
Sample solution of Alprazolam and Mebeverine 
HCl 
Twenty tablets were weighed and finely powdered. 
An accurately weighed portion of powder sample 
equivalent to 5 mg of Alprazolam and 5 mg of 
Mebeverine Hydrochloride was transferred into a 
100 ml clean dry volumetric flask containing 70 ml 
of 0.1M Hydrochloric acid. The solution was 
sonicated for 5 min and the drug was dissolved 
completely. The volume was made up to the mark 
with a further quantity of the Hydrochloric acid to 
get a stock concentration of Alprazolam and 
Mebeverine Hydrochloride. Further pipette 1 ml of 
the above stock solution into a 10 ml volumetric 
flask and the volume was made up to the mark with 
the 0.1M Hydrochloric acid. Absorbance of the 
sample solution was measured at 262.3 nm and 
222.5 nm. The data was presented in Table 1. 
Table 1: Assay results of Alprazolam and Mebeverine Hydrochloride formulations 
Formulation Label claim  Amount found %Assay 
MEBASAP-AL Alprazolam 5 mg 4.96 mg 99.20% 
Mebeverine HCl  5 mg 5.01 mg 100.02% 
METHOD VALIDATION 
Linearity 
Linearity was performed by preparing standard solutions in between the range of 3-15 µg/ml for both 
Alprazolam and Mebeverine Hydrochloride. The absorbance were measured at 262.3 nm for ALP and 222.5 
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nm for MBH. The linearity results were furnished in Table 2 and calibration curves were depicted in Fig. 3 
and Fig. 4. 
Table 2: Linearity results of Alprazolam and Mebeverine HCl 
S. No. Concentration (µg/ml) Absorbance (ALP) Absorbance (MBH) 
1 0 0 0 
2 3 0.196 0.108 
3 6 0.35 0.282 
4 9 0.531 0.446 
5 12 0.703 0.582 
  15 0.847 0.712 
Slope 0.055 0.5517 
Intercept 0.0277 0.0289 
Regression Equation(y) 0.0565x+0.0138 0.049x-0.0126 
Correlation Coefficient 0.9985 0.9965 
 
Fig. 3: Calibration curve of Alprazolam 
 
Fig. 4: Calibration curve of Mebeverine Hydrochloride 
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Precision 
Precision was evaluated by conducting intra-day and inter-day precision studies. The results were furnished 
in Table 3 and Table 4. 
Table 3: Results for Intra-day Precision 
S. No.  Time (Hours) Absorbance (ALP) Absorbance (MBH) 
1 0 0.472 0.364 
2 1 0.469 0.361 
3 2 0.465 0.363 
4 3 0.463 0.365 
5 4 0.462 0.36 
6 5 0.457 0.362 
7 6 0.458 0.359 
 Mean  0.46 0.36 
SD 0.0055 0.0022 
%RSD 1.18 0.597 
Table 4: Results for Inter-day Precision 
S. No.  Time (Days) Absorbance (ALP) Absorbance (MBH) 
1 0 0.479 0.391 
2 1 0.477 0.388 
3 2 0.466 0.392 
4 3 0.469 0.389 
5 4 0.473 0.388 
6 5 0.472 0.385 
7 6 0.472 0.385 
Mean 0.473 0.388 
SD 0.004 0.003 
%RSD 0.94 0.69 
Accuracy 
The accuracy of the method was determined by standard addition method. A known amount of standard 
drug was added to the fixed amount of pre-analyzed drug sample solution. Percent recovery was calculated 
by comparing the absorbance before and after the addition of the standard drug. The standard addition 
method was performed at three concentration levels in triplicate at 50%, 100% and 150%. The results were 
tabulated in Table 5 and Table 6.  
Table 5: Recovery studies for Alprazolam 
Level Standard conc. 
(µg/ml)  
Conc. added  
(µg/ml) 
Conc. found  
(µg/ml) 
% 
Recovery 
% Mean 
recovery 
50% 10 5 5.01 100.20  
99.84 100% 10 10 9.98 99.80 
150% 10 15 14.93 99.53 
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Table 6: Recovery studies for Mebeverine Hydrochloride 
Level Standard conc. 
(µg/ml)  
Conc. added  
(µg/ml) 
Conc. found  
(µg/ml) 
% 
Recovery 
% Mean 
recovery 
50% 10 5 4.97 99.40  
99.47 100% 10 10 9.93 99.30 
150% 10 15 14.96 99.73 
Limit of detection and Limit of quantification 
For this study six replicates of the analyte at lowest concentration were measured and quantified. The LOD 
and LOQ of Alprazolam and Mebeverine Hydrochloride are given in Table 7. 
Table 7: LOD and LOQ of Alprazolam and Mebeverine HCl  
Parameter Measured value (µg/ml) ALP Measured value (µg/ml) MBH 
Limit of detection 1.42 2.15 
Limit of quantification 4.32 6.54 
RESULTS AND DISCUSSION 
The proposed work describes a method used for the 
simultaneous estimation of Alprazolam and 
Mebeverine HCl by using 0.1M HCl as a solvent. The 
selected analytical wavelengths for were found to 
be 262.3 nm and 222.5 nm for ALP and MBH 
respectively. The calibration curve was constructed 
over a linear range of 3-15 µg/ml for both drugs 
ALP and MBH. The correlation coefficient was found 
to be 0.9985 for ALP and 0.9965 for MBH 
respectively. %RSD values of intra-day and inter-
day precision were found to be for ALP 1.18% and 
0.94% and for MBH 0.59% and 0.69%. For ALP the 
mean recovery was found to be 99.84% and for 
MBH 99.47%. LOD and LOQ values of developed 
method were found to be for ALP 1.42 (µg/ml) and 
4.3242 (µg/ml) and for MBH 2.1542 (µg/ml) and 
6.5442 (µg/ml). The %Assay of Alprazolam and 
Mebeverine HCl were found to be 99.20% and 
100.02% respectively.  
CONCLUSION  
The developed spectrophotometric method was 
simple, reproducible, accurate, rapid and cost-
effective method for simultaneous determination of 
ALP and MBH in bulk and pharmaceutical 
formulations. The method was validated for 
parameters like linearity, accuracy and precision as 
per ICH guidelines. All statistical results and assay 
results were found to be satisfactory. Hence the 
proposed method can be successfully employed for 
quantitative analysis of Alprazolam and Mebeverine 
HCl in combined dosage form.  
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